|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Autistic Disorder | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Child Development Disorders, Pervasive | |||||
| Mental Disorders | |||||
| Mental Disorders Diagnosed in Childhood | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Aripiprazole | |||||
| Placebo | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antipsychotic Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Bristol-Myers Squibb | |||||
| Otsuka America Pharmaceutical | |||||